Physician

Andrew S Jusko, MD

According to 2025 Medicare claims, Andrew Jusko, MD (NPI: 1154332740) practices ophthalmology in the Springfield, MA market, with the plurality of this provider's patient population coming from Hampden, MA. This provider's primary affiliated billing organization is ANDREW S JUSKO MD PC (NPI: 1053503912; TIN: 26-0335235) and primary practice location at 01089-5101.

Jusko's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,137 traditional Medicare patients, billed 3,447 HCPCS/CPT codes, and received $355,282 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 10,042 prescription claims across 1,729 beneficiaries totaling $606,582 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 29 records totaling $815. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $440,315 to $355,282. In contrast, Part D prescription costs have risen steadily, from $370,826 to $606,582. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$267K$534K2015 Medicare payment: $440,315 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $471,091 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $459,397 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $427,482 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $533,598 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $335,375 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $440,428 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $333,311 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $335,139 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $355,282 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,3874,148$440,315
20161,4414,336$471,091
20171,4374,127$459,397
20181,3423,730$427,482
20191,3883,910$533,598
20201,1092,823$335,375
20211,3483,824$440,428
20221,0313,024$333,311
20231,0533,239$335,139
20241,1373,447$355,282

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$423K$846K2015 Drug cost: $370,826 (USD; Tot_Drug_Cst)2016 Drug cost: $408,415 (USD; Tot_Drug_Cst)2017 Drug cost: $449,159 (USD; Tot_Drug_Cst)2018 Drug cost: $457,831 (USD; Tot_Drug_Cst)2019 Drug cost: $545,029 (USD; Tot_Drug_Cst)2020 Drug cost: $632,857 (USD; Tot_Drug_Cst)2021 Drug cost: $846,374 (USD; Tot_Drug_Cst)2022 Drug cost: $845,177 (USD; Tot_Drug_Cst)2023 Drug cost: $703,331 (USD; Tot_Drug_Cst)2024 Drug cost: $606,582 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151,0036,229$370,826
20161,1196,958$408,415
20171,1467,386$449,159
20181,1726,533$457,831
20191,2756,705$545,029
20201,3526,827$632,857
20211,6458,997$846,374
20221,5748,854$845,177
20231,5518,812$703,331
20241,72910,042$606,582

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system9651,190$87
92012Established patient problem focused exam of visual system298431$65
92083Exam of visual field with extended testing341377$48
92134Imaging of retina259301$31
92133Imaging of optic nerve247257$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine1749,690$191,374
CyclosporineCyclosporine20510,049$58,424
RhopressaNetarsudil Mesylate912,669$33,460
LumiganBimatoprost943,353$33,354
RocklatanNetarsudil Mesylat/Latanoprost702,862$32,761

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.29$815ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Andrew S. Jusko, MD?

Tedicare shows public-source Medicare data for Andrew S. Jusko, MD (NPI 1154332740), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew S. Jusko, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew S. Jusko, MD?

Andrew S. Jusko, MD is linked to ANDREW S JUSKO MD PC (billing NPI 1053503912) in the available physician profile data.

Does Andrew S. Jusko, MD have Open Payments data?

Andrew S. Jusko, MD has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.